107 related articles for article (PubMed ID: 6586046)
1. Hematopoietic stem cells in chronic myelogenous leukemia: abnormalities and behaviour.
Kohsaki M; Hara H
Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1589-97. PubMed ID: 6586046
[No Abstract] [Full Text] [Related]
2. Comparison between normal and leukemic colony-forming cells in vitro.
Kubota K; Miura Y
Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1577-82. PubMed ID: 6586045
[No Abstract] [Full Text] [Related]
3. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
4. [The pathophysiology of granuloid precursor cells in patients with chronic myelogenous leukemia (author's transl)].
Sanada M; Takahashi M; Kishi K; Moriyama Y; Shibata A
Rinsho Ketsueki; 1979 Dec; 20(12):1539-47. PubMed ID: 396388
[No Abstract] [Full Text] [Related]
5. [Colony-forming ability of bone marrow fibroblast precursor cells in chronic myeloid leukemia patients].
Zaritskiĭ AIu; Kazhdan IIa; Kulik MA; Lisovskaia VA; Iartseva NM
Ter Arkh; 1982; 54(8):120-3. PubMed ID: 6958076
[No Abstract] [Full Text] [Related]
6. [Practical value of cultured cells of the granulocyte-macrophage line (CFU-GM)].
Weiss I
Acta Haematol Pol; 1985; 16(3-4):179-84. PubMed ID: 3915173
[No Abstract] [Full Text] [Related]
7. [A case of chronic myelogeneous leukemia with erythrocytosis; increased CFU-E in chronic phase of the disease (author's transl)].
Suda K; Tsuboyama A; Kubota K; Mizoguchi H; Sakamoto S; Miura Y; Takaku F
Rinsho Ketsueki; 1980 Mar; 21(3):382-7. PubMed ID: 6931922
[No Abstract] [Full Text] [Related]
8. Culture studies in vitro in human leukemia.
Spitzer G; Verma DS; Dicke KA; McCredie KB
Semin Hematol; 1978 Oct; 15(4):352-78. PubMed ID: 366760
[No Abstract] [Full Text] [Related]
9. Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1.
Rao SG; Nadkarni KS; Joshi K; Kothari V; Advani SH
Indian J Exp Biol; 1984 Jun; 22(6):340-2. PubMed ID: 6595217
[No Abstract] [Full Text] [Related]
10. [Cytogenetical studies on erythropoietic and myelopoietic progenitor cells in vitro in chronic myelogenous leukemia (author's transl)].
Grilli G; Carbonell F; Fliedner TM
Haematologica; 1981 Dec; 66(6):733-9. PubMed ID: 6802714
[No Abstract] [Full Text] [Related]
11. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
12. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
13. Enhancement of human leukemic colony formation by mature granulocytes and autologous leukemic cells.
Motoji T; Mizoguchi H; Oshimi K; Fuchinoue M
Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1568-76. PubMed ID: 6586044
[No Abstract] [Full Text] [Related]
14. [Experimental and clinical use of cell cultures in chronic myeloid leukemia].
Burgaleta C; Soria H; Moreno T
Sangre (Barc); 1984; 29(4-B):549-64. PubMed ID: 6393382
[No Abstract] [Full Text] [Related]
15. [Proliferation and maturation of the hematopoietic cells in myelocytic leukemia in the stage of blast crisis].
Afanas'ev BV; Saĭdali MA; Zaritskiĭ AIu; Zabelina TS; Mikhaĭlova TG
Probl Gematol Pereliv Krovi; 1980 Apr; 25(4):15-21. PubMed ID: 6930083
[No Abstract] [Full Text] [Related]
16. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
[TBL] [Abstract][Full Text] [Related]
17. Comparison of colony-stimulating activities for evaluating in vitro granulomonopoiesis in normal subjects and in patients with myeloid leukemias.
López-Karpovitch X; Padrós-Semorile MR; Hurtado-Monroy R; Cárdenas MR; Niesvizky N; Martínez-Sánchez L; Rojas R
Rev Invest Clin; 1985; 37(4):323-7. PubMed ID: 3879370
[No Abstract] [Full Text] [Related]
18. Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia.
Pejsa V; Kusec R; Petrovecki M; Jaksic O; Jaksic B; Boranic M
Haematologica; 2003 Dec; 88(12):1429-31. PubMed ID: 14688001
[No Abstract] [Full Text] [Related]
19. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML).
Eaves AC; Eaves CJ
Exp Hematol; 1979; 7 Suppl 5():65-75. PubMed ID: 299448
[TBL] [Abstract][Full Text] [Related]
20. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
